Histogen, Inc.
Records under this name other than patents Histogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,257,947 | Extracellular matrix compositions produced under hypoxic culture conditions Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,524,494 | Low Oxygen Tension and BFGF Generates a Multipotent Stem Cell from a Fibroblast in Vitro Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,535,913 | Soluble composition for promoting hair growth produced by the hypoxic culture of fibroblast cells Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,538,736 | Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured Under Hypoxic Conditions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,274,276 | Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured Under Hypoxic Conditions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,530,415 | Repair And/Or Regeneration of Cells with a Composition Produced by Culturing Fibroblast Cells Under Hypoxic Conditions Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,512,403 | Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured under Hypoxic Conditions for Methods of Treating Tissue Injury Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,597,703 | Caspase Inhibitors and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,071,412 | Caspase Inhibitors and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,447,497 | (S)-3-(2-(4-(BENZYL)-3-Oxopiperazin-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,6-Tetrafluorophenoxy)PENTANOIC Acid Derivatives and Related Compounds as Caspase Inhibitors for Treating Cardiovascular Diseases Lapsed on the fee record Ended Sep 20, 2026 · High confidence | Lapsed on the fee record | Ended Sep 20, 2026 | High confidence |